OpenSAFELY Vaccine Coverage Report

Pfizer / Priority Group 1

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 23.5% 70,665 300,916 23.2% 0.3%
Sex Female 24.9% 47,642 191,233 24.6% 0.3%
Male 21.0% 23,023 109,683 20.7% 0.3%
Ethnicity White - British 23.8% 45,514 191,044 23.5% 0.3%
White - Irish 21.3% 532 2,499 21.0% 0.3%
White - Any other White background 22.4% 1,407 6,272 21.9% 0.6%
Mixed - White and Black Caribbean 10.5% 63 602 10.5% 0.0%
Mixed - White and Black African 11.1% 28 252 11.1% 0.0%
Mixed - White and Asian 15.2% 35 231 15.2% 0.0%
Mixed - Any other mixed background 16.2% 77 476 14.7% 1.5%
Asian or Asian British - Indian 21.4% 441 2,058 21.4% 0.0%
Asian or Asian British - Pakistani 15.2% 133 875 15.2% 0.0%
Asian or Asian British - Bangladeshi 13.6% 56 413 13.6% 0.0%
Asian or Asian British - Any other Asian background 20.6% 245 1,190 20.6% 0.0%
Black or Black British - Caribbean 13.5% 308 2,275 13.5% 0.0%
Black or Black British - African 16.9% 238 1,407 16.4% 0.5%
Black or Black British - Any other Black background 10.4% 77 742 10.4% 0.0%
Other ethnic groups - Chinese 22.0% 77 350 22.0% 0.0%
Other ethnic groups - Any other ethnic group 16.8% 196 1,169 16.2% 0.6%
Patients with any other ethnicity code 22.9% 8,876 38,822 22.6% 0.3%
Ethnicity not stated 24.2% 665 2,751 23.9% 0.3%
Ethnicity not recorded 24.5% 11,592 47,362 24.1% 0.4%
Ethnicity (broad categories) White 23.8% 47,467 199,829 23.5% 0.3%
Mixed 13.7% 217 1,582 13.3% 0.4%
South Asian 19.6% 896 4,564 19.5% 0.2%
Black 14.4% 637 4,438 14.2% 0.2%
Other 18.4% 280 1,519 18.4% 0.0%
Unknown 23.8% 21,140 88,949 23.5% 0.3%
Index of Multiple Deprivation 1 (most deprived) 24.4% 26,110 107,002 24.1% 0.3%
2 20.6% 10,479 50,799 20.3% 0.3%
3 22.1% 11,298 51,121 21.9% 0.2%
4 24.1% 11,830 48,986 23.9% 0.3%
5 (least deprived) 25.5% 10,479 41,153 25.2% 0.3%
Unknown 24.4% 448 1,834 24.4% 0.0%
Clinical Risk Groups Patients in Any Clinical Risk Group 23.4% 60,704 259,273 23.1% 0.3%
Patients with Immunosuppression 25.9% 2,366 9,149 25.6% 0.2%
Patients with CKD 27.0% 20,195 74,823 26.7% 0.3%
Patients who have Chronic Respiratory Disease 26.0% 7,238 27,881 25.6% 0.4%
Patients with Diabetes 24.7% 14,035 56,812 24.4% 0.3%
Patients with Chronic Liver disease 21.9% 1,715 7,840 21.5% 0.4%
Patients with CNS Disease (including Stroke/TIA) 23.3% 35,504 152,292 23.0% 0.3%
Patients with Chronic heart disease 26.1% 28,224 108,185 25.8% 0.3%
Patients with Asplenia or Dysfunction of the Spleen 24.2% 553 2,282 23.9% 0.3%
Patients with Wider Learning Disability 12.3% 5,530 44,968 12.0% 0.3%
Patients with Severe Mental Health 17.8% 5,327 30,002 17.5% 0.3%
Other Groups Patients who are shielding (High Risk from COVID-19) 25.1% 53,088 211,554 24.8% 0.3%
Patients with Morbid Obesity 19.5% 1,589 8,148 19.2% 0.3%
Patients who are pregnant 15.8% 21 133 15.8% 0.0%